MedTech analysis

United States, Cardiovascular Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes

$1,995.00

This report presents the prevalence and number of hospital discharges in the UnitedStates (U.S.) as well as the surgical procedure volumes for selected cardiovascular/thoracic diseases/disorders.

January 1, 2013

2018 ASH Pulse Survey

$599.00

This 9-question pulse survey of 102 hematologic oncologists practicing throughout the United States and Europe.

January 2, 2019

Germany, Surgical Procedure Volumes

$4,850.00

This report presents an overview of selected medical specialties and the number of surgical procedures performed for selected diseases/disorders in the European Union country of Germany.

October 1, 2013

Biomedtracker Q4 2020 Outlook Report

In this report, we cover catalysts from 35 drugs, devices, diagnostics, and deals expected to occur in Q4 2020. For each drug, the likelihood of Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are provided. These data points were provided using a combination of Pharmapremia, Informa’s drug development benchmarking product utilizing Biomedtracker’s LOA data to assist in informed decisions about drug pipeline prioritization, partnerships, and acquisitions, and drug approval data from Biomedtracker.

October 9, 2020

Drug Delivery: Injection Devices

Despite its relative invasiveness and technological maturity, instrument-based injection of pharmaceutical preparations is regarded as one of the most accurate, effective, reliable, and reproducible methods of therapeutic drug and fluid delivery.

December 17, 2019

U.S. Markets for General and Pelvic Endoscopic Surgery Products

This dynamic, new report from Medtech Insight includes analyses of products, current/forecast markets, surgical procedure volumes, competitors, and opportunities in the U.S. General and Pelvic Endoscopic Surgery Products Market.

Global Markets for Orthobiologics for the Repair and Regeneration of Bone

The management of musculoskeletal (MSK) disorders is dependent on several factors: geographic location location in the body, cause, patient history, and severity. Treatment options include lifestyle changes, pharmaceutical therapies, and interventional (ie device-based) therapies.

September 30, 2016

Joint Replacement Implants

The global market for joint replacement implants, which includes prostheses for the hips, knees, shoulders, elbows, ankles, and small joints, totaled nearly $16.4bn in 2017. This market is projected to increase at a compound annual growth rate of 3.8%, reaching nearly $19.8bn in 2022.

July 31, 2018

U.S. Markets for Obesity Drugs & Devices

$5,250.00

U.S. Markets for Obesity Drugs & Devices

Women’s Health: U.S. Markets for Female Urinary Incontinence Therapies

$3,750.00

This report focuses on minimally invasive therapy systems and medications designed for the treatment of female UI, including OAB pharmaceutical or drug treatments, injectable urethral bulking agents, and urethral sling systems, of which the OAB drug treatments market contributes the vast majority of revenues.

Robotically Assisted Surgical Devices Market

This comprehensive medical market and technology report provides an analysis and sales forecast for the global market for robotically assisted surgical (RAS) systems.

May 25, 2021

U.S. Cancer Statistics Update 2014

$1,950.00

This new report from Medtech Insight includes statistics for new cancer cases, prevalence, and deaths due to the disease in 2014.

Oncology: Surgical Ablation Devices Market

Valued at approximately $380m in 2017, the Surgical Ablation Devices Market for Oncology is expanding at a double-digit rate, driven by the increasing global prevalence of cancer and the growing demand for better healthcare in emerging markets.

June 19, 2018

Interventional Cardiology: Implantable Pacemaker Products

In 2020, the global market for implantable pacemaker products totaled nearly $3.9bn, with dual-chamber products accounting for nearly 75% of sales. Over the forecast period covered by this report, single-chamber pacemaker devices are expected to experience greater growth than the dual-chamber market, advancing at a CAGR of approximately 6.8%. Drivers include a growing prevalence of cardiovascular disease due to the aging population, the development of leadless pacemaker systems, and expanded indications. Additionally, there is strong evidence of a correlation between COVID-19 and the development of atrial arrythmias.

November 11, 2021